Jonathan G. Stine, MD MSc, FACP

After 8 yrs in academic medicine, I'm absolutely delighted to announce I’ve joined @AstraZeneca as a Global Clinical Lead. Starting today, I hope to advance innovative therapies for liver & metabolic diseases alongside an incredible team. Onward to this new chapter! #MASLD #MASH

What if you could reverse liver disease? By 2030, one in two adults is expected to have chronic liver disease. Penn State's @JonathanStineMD is using exercise as medicine to stop damage before it becomes deadly. bit.ly/4lOnpl9

Celebrated 8 incredible years of Stine Lab with a team lunch today! Grateful for the hard work, discoveries, and camaraderie that made our journey so impactful. Here’s to the science, the memories, and the friendships that last far beyond the lab. #MASLD #Research @PennStHershey

Thanks again for your interest in our work! Appreciate the chance to speak with the @GastroHep team about #exercise and #MASLD

New national survey of hepatology & GI providers: Despite 96% believing weight loss meds help #MASLD, 77% rarely/never prescribe them due to low comfort & limited training. Hunge thanks to @geneyim @MeenaBBansal for leading this effort 👉 journals.lww.com/jcge/abstract/…

Honored to receive the Hepatology Resident of the Year award last night. Deeply grateful to @PennStIMchiefs and @PennStGastroHep for the recognition. Thank you to my family, friends, and mentors, especially my dad and @JonathanStineMD, for your unwavering support and inspiration!…

So important to have real-world evidence on lifestyle interventions to further support the guidelines: journals.lww.com/hep/fulltext/9… @EASLedu @AlinaAllenMD @brennap9 #liverTwitter

👆Happy to share this latest publication from our group. This publication is very dear to me. Grateful to all my coauthors but especially to @PrajnaAnirvan for his tireless efforts in getting this published. @JonathanStineMD This is esp for you @EASLnews @AASLDtweets @APASLnews

MASH day was incredible! I learned so much today from Dr. Stine, Dr. Alkhouri, and Dr. Rotman - truly inspiring! @JonathanStineMD @AlkhouriNaim @NASH_and_coffee @PennStateGME @PennStIMchiefs

Coffee, science, clinical care and lions! #MASHDay2025

Coffee, science, clinical care. The perfect triad! #MASLD #MASH #Liver #MASHDay2025

Just a couple of #liver docs spending a Thursday together discussing all things #MASLD #MASH here @PennStHershey #MASHDay2025 @NASH_and_coffee @AlkhouriNaim @ChannapragadaV

Faculty Q&A is on 🔥 🔥 🔥 here @PennStHershey #MASHDay2025

Session #1 on epidemiology and clinical perspectives in #MASLD is in the books for @PennStHershey #MASHDay. Incredible talks and discussion from the audience and panelists! @KofiClarkeMD @ChannapragadaV @NASH_and_coffee @AlkhouriNaim

Full house from the moderator’s table here @PennStHershey #MASH Day 2025! @GlobalLiver #MASHDay2025 @KofiClarkeMD

Can’t wait to have @NASH_and_coffee @AlkhouriNaim join us tomorrow as invited speakers for @PennStHershey #MASH Day 2025! Looking forward to your talks and journal club!!

🌍 June 12 is Global Fatty Liver Day! A call to action against the silent epidemic of #MASLD and #MASH. Know your risk. Get screened. Take action. Liver health is essential. #FattyLiverDay #LiverHealth #EndMASLD #GlobalHealth #MASHAwareness2025

Thursday, June 12, join @PennStateHealth for #MASHDay 2025! Kicking off at 7:30 a.m. EST with a continental breakfast & Product Theatre. Live online & in‑person from the University Conference Center in Hershey. Don't miss the latest in #MASLD research! ce.med.psu.edu/mash/

✅ out this month’s issue‼️ Learn about:  📑 Role of muscle in MASLD❓ 📑 Optimal AFP cut-off in HCC screening in cured HCV?❓ 📑 Min meaningful diff in PROs in cirrhosis❓ 📑 How well are we treating itch in PSC❓ 📑 How best to 🔍 fibrosis in MetALD❓ journals.lww.com/hepcomm/pages/…